News
Positive Top-line Results of Pfizer’s Phase 3 Study Exploring Coadministration of Prevnar 20™ With Seasonal Flu Vaccine in Older Adults Released
Pfizer Inc. (NYSE:PFE) today announced positive top-line results from a Phase 3 study (B7471004) evaluating the safety and immunogenicity of PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine)
The Home Depot Update: Die Coronakrise macht uns alle zu Heimwerkern
American Express Declares Regular Quarterly Dividend
The Board of Directors of American Express Company (NYSE: AXP) has declared a regular quarterly dividend of $0.43 per common share, payable on November 10, 2021, to shareholders of record on
American Express Releases 2020-2021 Environmental, Social, and Governance Report with New Long-Term Goals
American Express (NYSE: AXP) today announced the release of its 2020-2021 Environmental, Social, and Governance (ESG) Report, which includes a new roadmap for the company’s ESG strategy focused on
Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they have submitted data to the U.S. Food and Drug Administration (FDA) from the Phase 2/3 trial of their COVID-19 vaccine in
Pfizer Starts Study of mRNA-Based Next Generation Flu Vaccine Program
Pfizer Inc. (NYSE: PFE) announced today that the first participants have been dosed in a Phase 1 clinical trial to evaluate the safety, tolerability, and immunogenicity of a single dose
Chevron Mourns Passing of Former Texaco Chairman Alfred DeCrane
Chevron Corporation today honored the life and career of former Texaco Chairman and CEO Alfred C. DeCrane, Jr., who died this past week at the age of 90.
This press release features multimedia
Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults
Pfizer Inc. (NYSE: PFE) today announced the start of the Phase 2/3 EPIC-PEP (Evaluation of Protease Inhibition for COVID-19 in Post-Exposure Prophylaxis) study to evaluate the investigational novel
NIKE, Inc. Reports Fiscal 2022 First Quarter Results
NIKE, Inc. (NYSE:NKE) today reported fiscal 2022 financial results for its first quarter ended August 31, 2021.
-
First quarter reported revenues were $12.2 billion, up 16 percent compared to
Walmart To Host ESG-Focused Discussion on Human Capital
Walmart Inc. (NYSE: WMT) announced today that Kathleen McLaughlin, executive vice president and chief sustainability officer & president of the Walmart Foundation will host a discussion on human
Pfizer Invites Public to View and Listen to Webcast of Pfizer November 2 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, November 2, 2021. The
Pfizer Declares Fourth-Quarter 2021 Dividend
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a 39-cent fourth-quarter 2021 dividend on the company’s common stock, payable December 6, 2021, to holders of the Common
5 Covered Call Trade Ideas - Targets 5%+ By Oct 8, 2021
Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine Booster
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the Pfizer-BioNTech
American Express Plans Live Audio Webcast of Third Quarter 2021 Earnings Conference Call
American Express Company (NYSE: AXP) plans to host a live audio webcast of its earnings conference call at 8:30 a.m. (ET) on Friday, October 22, 2021, to discuss third quarter 2021 financial
American Express and Extend Partner to Enable Virtual Cards for U.S. Small and Mid-Sized Businesses
Today, American Express (NYSE: AXP) and Extend, a New York City-based fintech specializing in virtual cards, announced their partnership to expand virtual Card solutions for U.S. businesses. U.S
Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to expand their agreement with the U.S. government by providing an additional 500 million doses of the companies’
American Express Commits to Net-Zero Emissions Globally By 2035
American Express (NYSE:AXP) today announced it has committed to net-zero carbon emissions by 2035, fifteen years ahead of the Paris Agreement’s 2050 goal. To achieve this ambition, the company will
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and CEO, at the Cantor Global Healthcare Conference on Monday
Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5 to
Iron Condor Option Trade In NKE Stock Could Return 33%
FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted
Chevron Accelerates Lower Carbon Ambitions
During its Energy Transition Spotlight, Chevron Corporation (NYSE: CVX) announced plans to invest more capital to grow lower carbon energy businesses.
“Chevron intends to be a leader in advancing
Chevron, Enterprise Explore Carbon Storage Business Opportunities
Chevron U.S.A. Inc., through its Chevron New Energies division, and a subsidiary of Enterprise Products Partners L.P. (NYSE: EPD) announced a framework to study and evaluate opportunities for
Chevron, Mercuria Announce CNG Fueling Network Joint Venture
Chevron U.S.A. Inc., a subsidiary of Chevron Corporation (NYSE: CVX), announced today the signing of definitive agreements to form a joint venture with Mercuria Energy Trading (Mercuria), one of